IFN receptor- (IFNAR-) induced nitric oxide synthase-2 expression was a PD-1 blockade sustained anticancer, a critical negative regulator of efficacy, which acted at the tumor cell and leucocyte levels [48]. The gene discussed is IFNAR1; the disease is neoplasm.